| Trial ID: | L4827 |
| Source ID: | NCT03829514
|
| Associated Drug: |
Fenofibrate
|
| Title: |
Fenofibrate in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT03829514/results
|
| Conditions: |
Diabetes Mellitus, Type II
|
| Interventions: |
DRUG: Fenofibrate
|
| Outcome Measures: |
Primary: Number of Individual Plasma Proteins That Changed From Baseline to End-point Based on Limma T-Test of Protein Abundance as Determined by Proteomic Analysis Via Liquid Chromatography-mass Spectrometry, Protein exclusive intensity values (counts/second) were normalized using cyclic loess normalization. Mean protein abundance as determined by the intensity for each protein was determined. 95% confidence intervals were calculated as a measure of dispersion. Paired means were compared using a Limma T-test and the p-value was adjusted for multiple comparisons using the Benjamini-Hochberg method. Mean Log2 Fold Change was calculated for each protein compared between 6 weeks and baseline. The number of proteins that changed between 6 weeks and baseline was zero., Six weeks, from baseline visit to study completion visit |
|
| Sponsor/Collaborators: |
Sponsor: Medical University of South Carolina
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2019-02-04
|
| Completion Date: |
2020-03-04
|
| Results First Posted: |
2022-02-08
|
| Last Update Posted: |
2023-10-24
|
| Locations: |
Medical University of South Carolina, Charleston, South Carolina, 29425, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT03829514
|
